Your browser doesn't support javascript.
loading
Effect of Obesity on Lung Function in the Pediatric and Adult Populations with Asthma: A Review.
Reyes Noriega, Nayely; Del-Río-Navarro, Blanca E; Berber, Arturo; de Jesús Romero Tapia, Sergio; Molina Díaz, Darío Jorge Mario.
Afiliação
  • Reyes Noriega N; Allergy and Immunology Pediatric Department, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
  • Del-Río-Navarro BE; Allergy and Immunology Pediatric Department, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
  • Berber A; Allergy and Immunology Pediatric Department, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
  • de Jesús Romero Tapia S; División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa 86280, Mexico.
  • Molina Díaz DJM; Pediatric Endocrinology Department, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.
J Clin Med ; 12(16)2023 Aug 19.
Article em En | MEDLINE | ID: mdl-37629427
ABSTRACT
Obesity and asthma are major global health concerns, particularly in industrialized nations. Obesity has been shown to have detrimental effects on the respiratory system and lung function owing to metabolic issues and immunological consequences. Research has indicated that obese patients with asthma (atopic or T2-high and non-atopic or T2-low) have diminished lung function in terms of functional residual capacity (FRC), residual volume (RV), expiratory reserve volume (ERV), the FEV1/FVC ratio, and FEF 25-75% due to mechanical fat loading on the diaphragm and central adiposity when compared to non-obese asthmatic patients. Therefore, it is plausible that changes in lung function are the result of a combination of mechanical (fat loading on the diaphragm, central adiposity, bronchial hyper-reactivity, and an increase in cholinergic tone), environmental (diet and exercise), and inflammatory factors (local and systemic), which can lead to the obesity-related asthma phenotype characterized by severe asthma symptoms, poor response to corticosteroid treatment, loss of lung function, and poor quality of life from an early age.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article